| ω-3 | Omega-3 Fatty Acids |
| ω-6 | Omega-6 Fatty Acids |
| ACC | Acetyl-CoA Carboxylase |
| AD | Alzheimer’s Disease |
| ADHD | Attention Deficit Hyperactivity Disorder |
| AEA | Anandamide |
| AHA | American Heart Association |
| ALA | ɑ-Linoleic Acid |
| APP | Amyloid Precursor Protein |
| ARA | Arachidonic Acid |
| ASAE | Autoridade de Segurança Alimentar e Económica |
| BBB | Blood-Brain Barrier |
| CAT1 | Carnitine Acetyltransferase 1 |
| CE | Cholesterol Esters |
| CHD | Coronary Heart Disease |
| CI | Confidence Interval |
| Cmax | Maximum Concentration |
| COX | Cyclooxygenase |
| cPLA2 | Cytosolic Phospholipase A2 |
| CRP | C-Reactive Protein |
| CV | Cardiovascular |
| CVD | Cardiovascular Disease |
| CYP | Cytochrome P450 |
| DAG | Diacylglycerols |
| DGAV | Direção-Geral da Alimentação e Veterinária |
| DGLA | Dihomo-γ-Linoleic Acid |
| DHA | Docosahexaenoic Acid |
| DiHOME | Dihydroxy-Octadecenoic Acid |
| DPA | Docosapentaenoic Acid |
| EE | Ethyl Esters |
| EET | Eicosatrienoic Acid |
| EFSA | European Food Safety Authority |
| ELOVL | Elongase |
| EPA | Eicosapentaenoic Acid |
| ETA | Eicosatetraenoic Acid |
| FA | Fatty Acid |
| FADS | Fatty Acid Desaturase |
| FAO | Food and Agriculture Organization |
| FDA | Food and Drug Administration |
| FFA | Free Fatty Acid |
| GDNF | Glial-Derived Neurotrophic Factor |
| GLA | γ-Linoleic Acid |
| HDL | High-Density Lipoprotein |
| HF | Heart Failure |
| HFrEF | Heart Failure Reduced Ejection Fraction |
| HODE | Hydroxy-Octadecadienoic Acid |
| HPA | Hypothalamic-Pituitary-Adrenal |
| INFARMED | Autoridade Nacional do Medicamento e Produtos de Saúde, I.P. |
| IL | Interleukin |
| IsoPs | Isoprostanes |
| IU | International Units |
| LA | Linoleic Acid |
| LCFA | Long-Chain Fatty Acid |
| LDL | Low-Density Lipoprotein |
| LOX | Lipoxygenase |
| LPL | Lipoprotein-Lipase |
| LT | Leukotrienes |
| MACE | Major Adverse Cardiovascular Events |
| MCFA | Medium-Chain Fatty Acid |
| MI | Myocardial Infarction |
| mtNOS | Mitochondrial Nitric Oxide Synthase |
| NeuroPs | Neuroprostanes |
| NNT | Number Needed to Treat |
| NO | Nitric Oxide |
| PD | Parkinson’s Disease |
| PFC | Prefrontal Cortex |
| PG | Prostaglandin |
| PGI | Prostacyclin |
| PhytoPs | Phytoprostanes |
| PL | Phospholipids |
| PPAR | Peroxisome Proliferator-Activated Receptor |
| PSEN1 | Presenilin 1 |
| PSEN2 | Presenilin 2 |
| PUFA | Polyunsaturated Fatty Acid |
| ROS | Reactive Oxygen Species |
| RR | Relative Risk |
| RvD1 | Resolvin D1 |
| SCFA | Short Chain Fatty Acid |
| SDA | Stearidonic Acid |
| SPM | Specialized Pro-resolvin Mediator |
| SREBP | Sterol Regulatory Element-Binding Protein |
| TAG | Triacylglycerols |
| TGF | Transforming Growth Factor |
| TNF | Tumor Necrosis Factor |
| TXA | Thromboxane |
| USA | United States of America |
| VEP | Visual-Evoked Potential |
| VFA | Volatile Fatty Acid |
| VLCFA | Very Long-Chain Fatty Acid |
| VLDL | Very-Low-Density Lipoproteins |
| WHO | World Health Organization |